For the quarter ended June 2025, Omega Healthcare Investors (OHI) reported revenue of $282.51 million, up 11.8% over the same period last year. EPS came in at $0.77, compared to $0.45 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $298.11 million, representing a surprise of -5.23%. The company delivered an EPS surprise of +2.67%, with the consensus EPS estimate being $0.75.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Omega Healthcare Investors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Rental income: $235.6 million compared to the $250.15 million average estimate based on two analysts. The reported number represents a change of +12% year over year.
- Revenues- Real estate tax and ground lease income: $3.61 million versus $3.82 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -7.9% change.
- Diluted- Net income (loss): $0.46 versus the three-analyst average estimate of $0.44.
View all Key Company Metrics for Omega Healthcare Investors here>>>
Shares of Omega Healthcare Investors have returned +6.4% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Omega Healthcare Investors, Inc. (OHI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
